Supplement | Sample reports

GUIDELINE UPDATES - This guideline was last updated 01/07/2022

This guideline is current until April 2025. Click the link below to access the latest guidelines.

Sample cervical screening reports

CERVICAL SCREENING	LOW RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Not detected
RECOMMENDATION	Rescreen in five years.

CERVICAL SCREENING	UNSATISFACTORY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: Unsatisfactory
RECOMMENDATION	Retest within six weeks.

CERVICAL SCREENING	UNSATISFACTORY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Image assisted: Unsatisfactory
RECOMMENDATION	Repeat screening test in six weeks.

CERVICAL SCREENING	INTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Manually Read: There is no evidence of a squamous intraepithelial lesion or malignancy Endocervical component: Present
RECOMMENDATION	Repeat test in 12 months.

CERVICAL SCREENING	INTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Image Assisted: Low grade intra-epithelial lesion (LSIL) Endocervical component: Present
RECOMMENDATION	Repeat test in 12 months.

CERVICAL SCREENING	HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC), Manually Read: High grade squamous intra-epithelial lesion (HSIL) Endocervical component: Present
RECOMMENDATION	Referral for Colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Detected HPV 18 – Not detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC), Manually Read: Unsatisfactory
RECOMMENDATION	Referral for Colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Image Assisted: Possible high grade squamous intra-epithelial lesion (pHSIL) Endocervical component: Not identified
RECOMMENDATION	Referral for Colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Manually Read: High grade squamous intra-epithelial lesion (HSIL) Endocervical component: Not identified
RECOMMENDATION	Referral for Colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Detected HPV 18 – Not detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC), Image Assisted: There is no evidence of a squamous intraepithelial lesion or malignancy Endocervical component: Present
RECOMMENDATION	Referral for Colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Manually Read: There is no evidence of a squamous intraepithelial lesion or malignancy Endocervical component: Present
RECOMMENDATION	In view of the previously reported abnormality referral for colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Image Assisted: Low grade squamous intra-epithelial lesion (LSIL) Endocervical component: Present
RECOMMENDATION	In view of the previously reported abnormality referral for colposcopic assessment.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected Liquid Based Cytology (LBC), Manually Read: Atypical endocervical cells of undetermined significance There is no evidence of a squamous intraepithelial lesion or malignancy
RECOMMENDATION	Referral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC), Image Assisted: Possible high grade glandular lesion The findings suggest possible adenocarcinoma-in-situ
RECOMMENDATION	Referral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – ThinPrep
TEST RESULTS	PCR for High Risk HPV and genotype: HPV 16 – Detected HPV 18 – Not detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC) Image Assisted: Squamous cell carcinoma There are abnormal cells that indicate origin from an invasive squamous cell carcinoma Endocervical component: Present
RECOMMENDATION	Colposcopy is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Cervical – SurePath
TEST RESULTS	PCR for High Risk HPV and genotype: HPV 16 – Not detected HPV 18 – Detected HPV (not 16/18) – Not detected Liquid Based Cytology (LBC), Manually Read: Endocervical adenocarcinoma
RECOMMENDATION	Colposcopy is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.

Sample stand alone LBC reports

SPECIMEN

Cervical – SurePath

TEST RESULTS

Liquid Based Cytology (LBC) Manually Read:

Low grade squamous intra-epithelial lesion (LSIL)
Endocervical component: Present

RECOMMENDATION

This woman is under specialist management, therefore no management recommendation is made.

SPECIMEN

Cervical – ThinPrep

TEST RESULTS

Liquid Based Cytology (LBC) Image assisted:

High grade squamous intra-epithelial lesion (HSIL)
Endocervical component: Present

RECOMMENDATION

This woman is under specialist management, therefore no management recommendation is made.

Reports for self-collected samples

CERVICAL SCREENING	LOW RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Lower vaginal sample – Self collected
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Not detected
RECOMMENDATION	Rescreen in five years.

CERVICAL SCREENING
SPECIMEN	Lower vaginal sample – Self collected
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Not detected HPV 18 – Not detected HPV (not 16/18) – Detected
RECOMMENDATION	Collect a cervical sample for LBC within six weeks.

CERVICAL SCREENING	HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN	Lower vaginal sample – Self collected
TEST RESULTS	PCR for Oncogenic HPV and genotype: HPV 16 – Detected HPV 18 – Not detected HPV (not 16/18) – Not detected
RECOMMENDATION	Refer for colposcopic assessment. Cervical sample for LBC can be obtained at time of that assessment.

CERVICAL SCREENING	UNSATISFACTORY
SPECIMEN	Lower vaginal sample – Self collected
TEST RESULTS	PCR for Oncogenic HPV and genotype: Unsatisfactory
RECOMMENDATION	Retest within six weeks.

Author(s):

A/Professor Lyndal Anderson — Co-author
Professor Marion Saville — Co-author
Professor Gordon Wright — Co-author
Cancer Council Australia Cervical Cancer Screening Guidelines Working Party — Co-author

WEBSITE UPDATES - This website was last updated 01/07/2022

Clinical Guidelines

Supplement: Sample reports

Supplement: Sample reports

Sample cervical screening reports

Sample stand alone LBC reports

Reports for self-collected samples